Type your tag names separated by a space and hit enter
Tocilizumab for thyroid eye disease
There's more to see -- the rest of this topic is available only to subscribers.
"Tocilizumab for Thyroid Eye Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435139/all/Tocilizumab_for_thyroid_eye_disease. Accessed 02 October 2023.
Tocilizumab for thyroid eye disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435139/all/Tocilizumab_for_thyroid_eye_disease. Accessed October 2, 2023.
Tocilizumab for thyroid eye disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435139/all/Tocilizumab_for_thyroid_eye_disease
Tocilizumab for Thyroid Eye Disease [Internet]. In: Cochrane Abstracts. [cited 2023 October 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435139/all/Tocilizumab_for_thyroid_eye_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tocilizumab for thyroid eye disease
ID - 435139
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435139/all/Tocilizumab_for_thyroid_eye_disease
DB - Evidence Central
DP - Unbound Medicine
Try the app for free!
1. Download the Evidence Central app by Unbound Medicine
2. Select Try/Buy and follow instructions to begin your free 30-day trial
You can cancel anytime within the 30-day trial, or continue using Evidence Central to begin a 1-year subscription ($39.95)
Your free 1 year of online access expired .
Want to regain access to Evidence Central?
Log in to Evidence Central
If you need further assistance, please contact Support.